DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Baselga J, Cortes J, Fumoleau P. et al
Pertuzumab and trastuzumab: re-responses to 2 biological agents in patients with HER2-positive breast cancer which had previously progressed during therapy with each agent given separately: a new biological and clinical observation.
Cancer Res 2009; 69 (Suppl.): Abstr. 5114-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.